Half of the patients who received an experimental vaccine for pancreas cancer being developed by Roche and BioNTech following ...

A new government report says that rates for precancerous lesions decreased about 80% among younger women who were screened ...

A University of Otago, Christchurch-led study is heralding the success of the HPV vaccination program, saying the cost and ...

A clinical trial demonstrates that personalised cancer vaccines effectively target mutations in high-risk kidney cancer, ...

A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the ...

A team of Yale researchers recently published promising results from a clinical trial testing the effectiveness of a new ...

A personalized vaccine demonstrated the potential to induce long-lasting immune response among people with advanced kidney ...

A recent CDC report further demonstrates the effectiveness of the HPV vaccine against cervical cancer. HPV is a sexually ...

The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...

Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...

Moderna Inc. expects to launch a personalized cancer vaccine that it’s developing with Merck & Co. by 2027, one of its top ...